Qualigen Therapeutics, Inc.
QLGN
$1.98
$0.08424.43%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
8/18/2025
-
Ticker Report
7/28/2025
-
GuruFocus
7/28/2025
-
GuruFocus
7/28/2025
-
GuruFocus
7/28/2025
-
GuruFocus
7/28/2025
-
TipRanks Financial Blog
7/28/2025
-
The Fly
7/28/2025
-
Globe Newswire
7/28/2025
-
TipRanks Financial Blog
7/28/2025
-
GuruFocus
7/28/2025
-
GuruFocus
7/28/2025
-
Globe Newswire
7/19/2025
-
MarketBeat
7/17/2025
-
TipRanks Financial Blog
7/16/2025
-
MarketBeat
7/16/2025
-
GuruFocus
7/16/2025
-
The Fly
7/16/2025
-
Globe Newswire
5/19/2025
-
GuruFocus
5/19/2025
-
GuruFocus
5/19/2025
-
GuruFocus
5/19/2025
-
TipRanks Financial Blog
5/19/2025
-
Globe Newswire
5/1/2025
-
GuruFocus
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, July 21, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Nov 10 and 14 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
760 452 8111
Address
5857 Owens Avenue
Carlsbad, CA 92008
Carlsbad, CA 92008
Country
Year Founded
Business Description
Sector
Qualigen Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of treatments for adult and pediatric cancer. The company’s lead program is QN-302, an...
more